Stifel raised the firm’s price target on Intuitive Surgical (ISRG) to $610 from $525 and keeps a Buy rating on the shares. After having had in-depth conversations with five early-adopting U.S. da Vinci 5 robotic system physicians now roughly eight months post FDA approval, the firm says early physician DV5 feedback was “highly-encouraging,” adding that these physicians’ robotic surgery adoption appears “all-in.”
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ISRG:
- Intuitive Surgical assumed at Overweight from Equal Weight at Morgan Stanley
- Intuitive Surgical price target raised to $561 from $535 at BTIG
- Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules
- Workday initiated, Kraft Heinz downgraded: Wall Street’s top analyst calls
- Intuitive Surgical upgraded to Buy at Erste on ‘excellent market position’
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
